Evidence method
Level · gp.fundamentals.capex_revenue_ratio
-0.90% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
VRCA · Sep 30, 2024
Verrica Pharmaceuticals Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-24-120982General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
-161.06% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
-145.09% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
1162.49% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
-118.36% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20240/5 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20252/7 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 0.21%
- Current
- -0.90%
- Delta
- -1.11%
- Previous
- 2744.51%
- Current
- -161.06%
- Delta
- -2905.56%
- Previous
- 52.23%
- Current
- -145.09%
- Delta
- -197.32%
- Previous
- -293.72%
- Current
- 1162.49%
- Delta
- 1456.22%
- Previous
- 43.04%
- Current
- -118.36%
- Delta
- -161.40%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · VRCA Fundamental State →Has State · Verrica Pharmaceuticals Inc. →Transitioned To · VRCA Fundamental State →Transitioned To · VRCA CAPEX_INTENSITY_DECREASED →Transitioned To · VRCA GROWTH_DECREASED →Transitioned To · VRCA INVENTORY_PRESSURE_DECREASED →Transitioned To · VRCA PROFITABILITY_INCREASED →Transitioned To · VRCA SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.